🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these accounts privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, physicians and chemists have cautions that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer laws, risking fines, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the platform has removed violative content and banned related hashtags and query recommendations. The company stated it was committed to keeping the service safe and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, glowing reviews and detailed guides for preparing or administering at residence.

After moments of joining one community, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Details and Costs

Inside these groups, messages display black plastic packages with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram said it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant health risks”.